Tranexamic Acid

1. INCI et CAS

INCI: Tranexamic Acid · CAS: 1197-18-8

2. Rôle dans la formule

Cosmetic guides often explore about 2–3% tranexamic acid in leave-on serums. This page does not claim a medicine, a injection use, or a guaranteed spot result.

3. Niveaux d'emploi typiques (repère de formulation)

• For serums, the reference gives 2–3% where the market allows in this reference.

Dissolve into water. Confirm the destination cosmetic listing before filing.

4. Sources réglementaires et conformité mondiale

• The CosIng record for Tranexamic Acid, where listed, is informational rather than product-specific authorization.
• The EU Cosmetics Regulation (EC) No 1223/2009 requires a safety assessment of the finished cosmetic containing Tranexamic Acid for the product in its final form.
• Review the documentation for the actual Tranexamic Acid grade and the filing requirements for the target market.

5. Sécurité et évaluation des risques

The use-level note is a reference for cosmetic formulation; it provides no evidence that a drug or OTC monograph applies and the completed cosmetic needs its own patch and stability checks.

6. Stabilité et conditionnement

Protect the sealed bulk from heat, sun, and unnecessary exposure; match the pack choice to the system's oxidation risk; test the selected package with the confirmed batch for stability and fit.

7. Formulations d'allégations (à faire / à éviter)

• The recorded cosmetic positioning for Tranexamic Acid highlights tranexamic-acid cosmetic.

• The development record does not demonstrate drug or therapeutic claims, clinical cures, or certification claims not confirmed for the product.
• This Tranexamic Acid listing should not be used to substantiate a whitening effect, acne treatment, perspiration control, sun protection, or hair growth.

1. INCI et CAS

INCI: Glycerin · CAS: 56-81-5

2. Rôle dans la formule

The reference uses glycerin as a polyol humectant across washes, gels, and emulsions. Treat the percentage as development guidance.

3. Niveaux d'emploi typiques (repère de formulation)

• 3–8% is listed for gels and serums as a formulation guide.
• For creams, the reference gives 2–5% for the formula.
• For rinse-off, the reference gives 2–4% in this reference.

The water phase is the addition point for Glycerin; a separate melt is unnecessary.

4. Sources réglementaires et conformité mondiale

• A CosIng listing for Glycerin provides ingredient information, not approval of a supplied grade or finished product.
• Before EU placement, Regulation (EC) No 1223/2009 requires the final cosmetic with Glycerin to undergo a safety assessment as a finished-product assessment.
• Confirm the actual Glycerin grade from supplier documentation and check requirements where the product will be sold.

5. Sécurité et évaluation des risques

The guide records a level for cosmetic formulation purposes; it is not evidence of drug approval or OTC authorization with patch and stability testing still needed for the completed formula.

6. Stabilité et conditionnement

Protect the sealed bulk from heat, sun, and unnecessary exposure; if the formula is oxidation-sensitive, an airless or pump format may be considered; confirm compatibility and stability using the selected formula and pack.

7. Formulations d'allégations (à faire / à éviter)

• For cosmetic use, this entry records Glycerin in a direction centered on humectant function.

• The cosmetic listing does not substantiate drug effects, clinical cures, or unsupported product certifications.
• The information about Glycerin does not confirm whitening, acne treatment, antiperspirant effects, sunscreen use, or hair growth.

1. INCI et CAS

INCI: Squalane · CAS: 111-01-3

2. Rôle dans la formule

Squalane provides the referenced hydrocarbon-emollient role in a plant-derived grade; mineral oil is not part of this guide.

3. Niveaux d'emploi typiques (repère de formulation)

• Formulation guidance for gel-creams: 2–6% for the formula.
• The dry oils use-level reference is 10–30% as a formulation guide.
• Formulation guidance for balms: 5–15% in this reference.

Add Squalane to the oil phase; no high-shear wax step is required.

4. Sources réglementaires et conformité mondiale

• A CosIng listing for Squalane provides ingredient information, not approval of a supplied grade or finished product.
• Regulation (EC) No 1223/2009 requires the final cosmetic with Squalane to undergo a safety assessment at the level of the finished cosmetic product.
• Confirm the received Squalane grade against supplier documentation, then verify the intended market's filing requirements.

5. Sécurité et évaluation des risques

The use-level note is a reference for cosmetic formulation; it should not be read as a drug authorization or OTC listing and patch and stability testing remain part of finished-product review.

6. Stabilité et conditionnement

For bulk storage, avoid warmth and direct sun and keep the container closed; review airless or pump options if oxidation presents a concern; assess the confirmed formula for stability and package compatibility.

7. Formulations d'allégations (à faire / à éviter)

• The cosmetic role of Squalane is presented as a light-emollient role.

• This formulation entry cannot substantiate drug or therapeutic claims, clinical cures, or certification claims not confirmed for the product.
• The ingredient record for Squalane does not confirm whitening, acne treatment, antiperspirant effects, sunscreen use, or hair growth.